biocon: Biocon acquires Eywa Pharma’s US-based plant for $7.7 million
Biotechnology main Biocon on Saturday stated its unit has acquired Eywa Pharma Inc's oral strong dosage manufacturing facility within the ...
Biotechnology main Biocon on Saturday stated its unit has acquired Eywa Pharma Inc's oral strong dosage manufacturing facility within the ...
Copyright © 2022 Asia Today.